Form 4: Carlyle Group Sells QuidelOrtho Corp Shares Under 10b5-1 Trading Plan

Carlyle Group Inc. sold shares of QuidelOrtho Corp (QDEL) between July 10 and July 11, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Carlyle Group Inc. sold shares of QuidelOrtho Corp (QDEL) on July 10 and July 11, 2024.
• The sales were executed under a Rule 10b5-1 trading plan adopted on May 12, 2024.
• On July 10, 2024, 24,390 shares were sold at a weighted average price of $30.0931, with prices ranging from $30.00 to $30.23.
• On July 11, 2024, multiple transactions occurred: 4,724 shares were sold at a weighted average price of $30.6844 (ranging from $30.10 to $30.9998), 91,594 shares were sold at a weighted average price of $31.408 (ranging from $31.00 to $31.9998), and 260 shares were sold at a weighted average price of $32.0096 (ranging from $32.00 to $32.0336).
• Following these transactions, Carlyle Group's indirect beneficial ownership stands at 11,045,002 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document simply reports transactions under a pre-existing trading plan. There is no indication of positive or negative outlook.

Industry Context

Share sales by major holders like Carlyle Group are common and can reflect portfolio management decisions. The use of a 10b5-1 plan suggests the sales were pre-planned and not based on recent market information.

Stakeholder Impact

• The share sales may have a minor impact on shareholders due to the increased supply of shares in the market, but the pre-planned nature of the sales mitigates concerns about insider trading or a negative outlook by Carlyle Group.

Key Dates